Preclinical Studies of Signaling Pathways in a Mutant Mouse Model of Hormone-Refractory Prostate Cancer

doi 10.21236/ada549157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Hormone-Refractory Prostate Cancer

English

Molecular Characterization of the Gγ-globin-Tag Transgenic Mouse Model of Hormone Refractory Prostate Cancer: Comparison to Human Prostate Cancer

Prostate
OncologyUrology
2010English

Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
2007English

CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC)

Japanese Journal of Urology
Urology
2006English

Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2017English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Linking DNA Damage and Hormone Signaling Pathways in Cancer

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2016English

Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy